- ¥243bn
- ¥215bn
- ¥47bn
- 98
- 40
- 62
- 78
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 16.33 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | -0.97% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 4.28 | ||
| Price to Tang. Book | 5.26 | ||
| Price to Free Cashflow | 11.24 | ||
| Price to Sales | 5.21 | ||
| EV to EBITDA | 9.19 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 28.39% | ||
| Return on Equity | 30.92% | ||
| Operating Margin | 45.23% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | ¥m | 11,677.25 | 9,422.21 | 26,852.43 | 28,712.19 | 46,676.52 | 46,564 | 48,381 | 45.26% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +85.2 | -50.36 | +194.11 | -59.41 | +397.71 | -3.89 | +5.89 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
PeptiDream Inc. is a Japan-based bio-venture company started by the University of Tokyo and principally engaged in the discovery and development of non-standard peptide therapeutics. The Company operates the Peptide Discovery Platform System (PDPS), a drug development platform system and conducts research and development (R&D) on new drug candidates based on the joint R&D with pharmaceutical companies in Japan and overseas. The Company is involved in the business centered on drug development based on special peptides. The Company's businesses include drug discovery joint R&D, PDPS technology loan (PDPS technology license) and expansion of its own pipeline through strategic alliance (strategic alliance or in-house drug discovery).
Directors
- Patrick Reid PRE (46)
- Kiyofumi Kaneshiro VPR (43)
- Keiichi Masuya VPR (52)
- Yukinori Hanafusa IND (46)
- Toshio Nagae IND (77)
- Michio Sasaoka IND (71)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- July 3rd, 2006
- Public Since
- June 11th, 2013
- No. of Shareholders
- 23,854
- No. of Employees
- 621
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
Tokyo Stock Exchange- Shares in Issue
- 129,611,765
- Address
- 3-25-23, Tono-machi, Kawasaki-ku, KAWASAKI-SHI, 210-0821
- Web
- https://www.peptidream.com/
- Phone
- +81 442701300
- Auditors
- KPMG AZSA LLC
Upcoming Events for 4587
Dividend For 4587.T - 0.0000 JPY
Q2 2025 PeptiDream Inc Earnings Release
Similar to 4587
3-D Matrix
Tokyo Stock Exchange
AnGes
Tokyo Stock Exchange
BrightPath Biotherapeutics Co
Tokyo Stock Exchange
Carna Biosciences
Tokyo Stock Exchange
Chiome Bioscience
Tokyo Stock Exchange
FAQ
What is the PeptiDream share price?
As of Today at 22:36 UTC, shares in PeptiDream are trading at ¥1,876. This share price information is delayed by 15 minutes.
How has the PeptiDream share price performed this year?
Shares in PeptiDream last closed at ¥1,876 and the price had moved by +27.75% over the past 365 days. In terms of relative price strength the PeptiDream share price has outperformed the Nikkei 225 Index by +39.52% over the past year.
What are the analyst and broker recommendations for PeptiDream?
The overall consensus recommendation for PeptiDream is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the PeptiDream dividend yield?
PeptiDream does not currently pay a dividend.
Does PeptiDream pay a dividend?
PeptiDream does not currently pay a dividend.
When does PeptiDream next pay dividends?
PeptiDream does not currently pay a dividend.
How do I buy PeptiDream shares?
To buy shares in PeptiDream you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of PeptiDream?
As of the previous close price of ¥1,876, shares in PeptiDream had a market capitalisation of ¥243bn.
Where are PeptiDream shares listed?
Here are the trading details for PeptiDream:
- Country of listing: Japan
- Exchange: TYO
- Ticker Symbol: 4587
What kind of share is PeptiDream?
Based on an overall assessment of its quality, value and momentum PeptiDream is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a PeptiDream share price forecast for 2025?
The analyst consensus target price for shares in PeptiDream is ¥3,588. That is 91.23% above the last closing price of ¥1,876.
Analysts covering PeptiDream currently have a consensus Earnings Per Share (EPS) forecast of ¥113 for the next financial year.
Find out moreWhat is the trend in the PeptiDream share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like PeptiDream. Over the past six months, its share price has underperformed the Nikkei 225 Index by -26.01%.
As of the last closing price of ¥1,876, shares in PeptiDream were trading -23.4% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the PeptiDream PE Ratio?
The PeptiDream PE ratio based on its reported earnings over the past 12 months is 16.33. The shares last closed at ¥1,876.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of PeptiDream?
PeptiDream's management team is headed by:
- Patrick Reid - PRE
- Kiyofumi Kaneshiro - VPR
- Keiichi Masuya - VPR
- Yukinori Hanafusa - IND
- Toshio Nagae - IND
- Michio Sasaoka - IND